Delivery Order SPE2DB22D1106-SPE2DB25FFDJ0
- Not listed
- The Defense Logistics Agency awarded a $10,016.78 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed price contract, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injections with a ceiling value of $5,936.87. This delivery order represents a firm fixed price contract with no set-aside designation, executed under competitive procurement procedures. The award is expected to be completed by August 4, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,785.41 on June 17, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This non-competitive, firm fixed-price delivery order is expected to be completed by June 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injections. This competitively awarded, non-set-aside contract has a ceiling value of $10,683.61 with a firm fixed price structure and is scheduled for completion by May 5, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a contract value of $15,251.60. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 12, 2025, with the place of performance located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a $12,636.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on August 29, 2025, with a completion date of September 2, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $4,177.46. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $4,410.85 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections on September 15, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,443.38 to supply Zepbound 5 mg/0.5 ml pen injectors, with completion targeted for August 20, 2025. This competitive award, issued on August 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,476.18 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injections on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDJ0Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injections in 0.5 ml quantities. This firm fixed price delivery order, valued at $12,600.16, represents a non-competitive award executed under a larger indefinite delivery contract vehicle. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The Zepbound order reflects the company's role in providing specialized pharmaceutical products to federal healthcare customers, including the Defense Health Agency and other government medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 8/14/25 |